https://orcid.org/0000-0003-0796-0496
Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Frank Lavernia & Lawrence Blonde. (2020) Clinical review of the efficacy and safety of oral semaglutide in patients with type 2 diabetes compared with other oral antihyperglycemic agents and placebo. Postgraduate Medicine 132:sup2, pages 15-25.
Read now
Read now
Stephen A. Brunton, Ofri Mosenzon & Eugene E. Wright Jr. (2020) Integrating oral semaglutide into clinical practice in primary care: for whom, when, and how?. Postgraduate Medicine 132:sup2, pages 48-60.
Read now
Read now
Articles from other publishers (8)
Jaianny Chaves Braga, Laura Alves de Aguiar Glória Barbosa, Samyra Giarola Cecílio & Larissa Mirelle de Oliveira Pereira. (2024) SIBUTRAMINA E LIRAGLUTIDA NA TERAPÊUTICA DA OBESIDADE. Revista Contemporânea 4:4, pages e4034.
Crossref
Crossref
Tanya Saxena, Claire Sie, Kristine Lin, Daisy Ye, Katayoun Saatchi & Urs O. Häfeli. (2022) Potential of Nuclear Imaging Techniques to Study the Oral Delivery of Peptides. Pharmaceutics 14:12, pages 2809.
Crossref
Crossref
Mohamed Sayed Zaazouee, Aboalmagd Hamdallah, Sara Kamel Helmy, Elfatih A. Hasabo, Ahmed Kamal Sayed, Mohamed Ibrahim Gbreel, Aya Abd Elmegeed, Hala Aladwan, Alaa Ahmed Elshanbary, Walid Abdel-Aziz, Israa Mohamed Elshahawy, Shehab Rabie, Sherouk Elkady, Ahmed Said Ali, Khaled Mohamed Ragab & Anas Zakarya Nourelden. (2022) Semaglutide for the treatment of type 2 Diabetes Mellitus: A systematic review and network meta-analysis of safety and efficacy outcomes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 16:6, pages 102511.
Crossref
Crossref
Zhaotong Cong, Qingtong Zhou, Yang Li, Li-Nan Chen, Zi-Chen Zhang, Anyi Liang, Qing Liu, Xiaoyan Wu, Antao Dai, Tian Xia, Wei Wu, Yan Zhang, Dehua Yang & Ming-Wei Wang. (2022) Structural basis of peptidomimetic agonism revealed by small-molecule GLP-1R agonists Boc5 and WB4-24. Proceedings of the National Academy of Sciences 119:20.
Crossref
Crossref
Zaynab Ahmad Mouhammad, Rupali Vohra, Anna Horwitz, Anna-Sophie Thein, Jens Rovelt, Barbara Cvenkel, Pete A. Williams, Augusto Azuara-Blanco & Miriam Kolko. (2022) Glucagon-Like Peptide 1 Receptor Agonists – Potential Game Changers in the Treatment of Glaucoma?. Frontiers in Neuroscience 16.
Crossref
Crossref
Marc Evans, Angharad R. Morgan, Stephen C. Bain, Sarah Davies, Debbie Hicks, Pam Brown, Zaheer Yousef, Umesh Dashora, Adie Viljoen, Hannah Beba & W. David Strain. (2022) Meeting the Challenge of Virtual Diabetes Care: A Consensus Viewpoint on the Positioning and Value of Oral Semaglutide in Routine Clinical Practice. Diabetes Therapy 13:2, pages 225-240.
Crossref
Crossref
Zhaotong Cong, Li-Nan Chen, Honglei Ma, Qingtong Zhou, Xinyu Zou, Chenyu Ye, Antao Dai, Qing Liu, Wei Huang, Xianqiang Sun, Xi Wang, Peiyu Xu, Lihua Zhao, Tian Xia, Wenge Zhong, Dehua Yang, H. Eric Xu, Yan Zhang & Ming-Wei Wang. (2021) Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor. Nature Communications 12:1.
Crossref
Crossref
Hans-Rudolf Berthoud, Vance L. Albaugh & Winfried L. Neuhuber. (2021) Gut-brain communication and obesity: understanding functions of the vagus nerve. Journal of Clinical Investigation 131:10.
Crossref
Crossref